Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT06715501 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06715501
- Sponsor
- First Affiliated Hospital of Ningbo University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.